Vaccitech Stock Analysis

The big decline in price over the last few months for Vaccitech Plcmay raise some interest from investors as it is trading at a share price of 0.0 on very low momentum in trading volume. The company management teams failed to add value to investors and positioning the company supply of money to exploit market volatility in December. However, diversifying your holdings with Vaccitech Plc ADR or any similar stocks can still protect your portfolios during high-volatility market scenarios. The stock standard deviation of daily returns for 90 days investing horizon is currently 3.73. The above-average risk is mostly attributed to market volatility and speculations regarding some of the upcoming earning calls from Vaccitech Plc ADR partners.
Check out World Market Map.

Vaccitech Stock Analysis 

 
Refresh
The Vaccitech Plc stock analysis report makes it easy to digest most publicly released information about Vaccitech Plc and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. Vaccitech Stock analysis module also helps to analyze the Vaccitech Plc price relationship with some important fundamental indicators such as market cap and management efficiency.

Vaccitech Stock Analysis Notes

About 30.0% of the company outstanding shares are owned by insiders. The company has Price to Book (P/B) ratio of 1.41. Historically many companies with similar price-to-book (P/B) ratio do better than the market in the long run. Vaccitech Plc ADR recorded a loss per share of 4.16. The entity had not issued any dividends in recent years. Vaccitech plc, a clinical-stage biopharmaceutical company, engages in the discovery and development of novel T cell immunotherapeutics and vaccines for the treatment and prevention of infectious diseases and cancers. Vaccitech plc was founded in 2016 and is headquartered in Oxford, the United Kingdom. Vaccitech Plc operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 48 people. For more information please call the company at 44 1865 818 808 or visit https://www.vaccitech.co.uk.

Vaccitech Plc ADR Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Vaccitech Plc's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Vaccitech Plc ADR or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Vaccitech Plc ADR is not yet fully synchronised with the market data
Vaccitech Plc ADR generated a negative expected return over the last 90 days
Vaccitech Plc ADR has some characteristics of a very speculative penny stock
Vaccitech Plc ADR has high historical volatility and very poor performance
The company reported the previous year's revenue of 622.26 K. Net Loss for the year was (46.21 M) with loss before overhead, payroll, taxes, and interest of (9.57 M).
Vaccitech Plc ADR currently holds about 233.87 M in cash with (29.51 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 6.71.
Roughly 30.0% of the company outstanding shares are owned by insiders

Vaccitech Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Vaccitech Plc is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Vaccitech Plc ADR backward and forwards among themselves. Vaccitech Plc's institutional investor refers to the entity that pools money to purchase Vaccitech Plc's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Security TypeSharesValue
Mg Investment Management LtdCommon Shares1.1 M17.4 M
Dc Funds LpCommon Shares642.2 K10.1 M
Liontrust Investment Partners LlpCommon Shares600 K9.4 M
Tudor Investment Corp Et AlCommon Shares378.3 K5.7 M
Hudson Bay Capital Management LpCommon Shares189.3 KM
Millennium Management LlcCommon Shares118.3 K1.9 M
Ipswich Investment Management Co IncCommon Shares51.5 K810 K
Note, although Vaccitech Plc's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Vaccitech Market Capitalization

The company currently falls under 'Small-Cap' category with current market capitalization of 346.7 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Vaccitech Plc's market, we take the total number of its shares issued and multiply it by Vaccitech Plc's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

Management Efficiency

Vaccitech Plc management efficiency ratios could be used to measure how well vaccitech plc adr manages its routine affairs as well as how well it operates its assets and liabilities.

Vaccitech Plc ADR Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Vaccitech Plc insiders, such as employees or executives, is commonly permitted as long as it does not rely on Vaccitech Plc's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Vaccitech Plc insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Vaccitech Plc Technical and Predictive Indicators

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Vaccitech Plc to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Volatility Analysis Now

   

Volatility Analysis

Get historical volatility and risk analysis based on latest market data
All  Next Launch Module
Check out World Market Map. Note that the Vaccitech Plc ADR information on this page should be used as a complementary analysis to other Vaccitech Plc's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Bond Directory module to find actively traded corporate debentures issued by US companies.

Other Tools for Vaccitech Stock

When running Vaccitech Plc ADR price analysis, check to measure Vaccitech Plc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vaccitech Plc is operating at the current time. Most of Vaccitech Plc's value examination focuses on studying past and present price action to predict the probability of Vaccitech Plc's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Vaccitech Plc's price. Additionally, you may evaluate how the addition of Vaccitech Plc to your portfolios can decrease your overall portfolio volatility.
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Go
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Go
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Go
CEO Directory
Screen CEOs from public companies around the world
Go
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Go
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Go
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Go
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Go
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Go
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Go
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Go